Patients , stratified by disease measurability and participating site , were randomly assigned ( 1:1 ) to receive capecitabine 1000mg/m ( 2 ) twice daily for 14 days and cisplatin 80 mg/m ( 2 ) on day 1 every 3 weeks plus either simvastatin 40 mg or placebo , once daily .